Hansoh Pharmaceutical cuts convertible bond conversion price to HK$56.54 per share

• Hansoh Pharmaceutical adjusted the conversion price on its HK$ 4.68 billion zero-coupon convertible bonds due 2033.
• Conversion price cuts to HK$ 56.54 from HK$ 57.39, effective Sept. 28, 2026, following the interim dividend record date.
• Maximum shares issuable on full conversion rise to 82,773,258 from 81,547,308.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260826-12300975), on August 26, 2026, and is solely responsible for the information contained therein.